Streetbeat News

Revenues

QTWO

Q2 Holdings (NYSE:QTWO) has received diverse ratings from 8 analysts, with an average 12-month price target of $40.12, reflecting a 19.16% increase from the previous target. Analysts from firms like Goldman Sachs and Morgan Stanley have raised their price targets, indicating a positive outlook for QTWO. The company provides cloud-based virtual banking solutions and has shown a revenue growth rate of 7.06% as of September 30, 2023. However, it faces challenges with a net margin of -14.95% and an ROA of -1.97%, though it has a favorable debt-to-equity ratio of 1.24.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:01 pm

TXRH

Texas Roadhouse (NASDAQ:TXRH) received mixed analyst ratings with 1 bullish, 3 somewhat bullish, and 3 indifferent. The 12-month price targets have an average of $119.14, with a high of $130.00 and a low of $110.00. Recent analyst actions include adjustments to ratings and price targets by JP Morgan, Wedbush, Piper Sandler, Truist Securities, and Morgan Stanley. Texas Roadhouse's financial health indicators show a solid revenue growth rate of 12.93%, an impressive net margin of 5.69%, an exceptional ROE of 5.83%, and an effective ROA of 2.52%, with a conservative debt-to-equity ratio of 0.69.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:01 pm

NBIX

Over the past three months, 13 analysts have provided varied opinions on Neurocrine Biosciences (NASDAQ:NBIX), with recent ratings showing a shift towards a more bullish stance. The average 12-month price target is now $127.54, up from $121.70, with individual targets ranging from $100.00 to $150.00. Analysts have made adjustments to their ratings and price targets, reflecting changes in market conditions and company performance. Neurocrine Biosciences is a pharmaceutical company with late-stage clinical programs for CNS and endocrine-related conditions. Financial indicators show a positive revenue trend, high net margin, and strong ROE and ROA, with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:00 pm

CAKE

Cheesecake Factory (NASDAQ:CAKE) received mixed ratings from 7 analysts, with a shift towards a more bearish stance in the last 30 days. The average 12-month price target is $32.14, down 5.47% from the previous average. Analysts from firms like JP Morgan, Wedbush, Piper Sandler, Barclays, and Stephens & Co. have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Cheesecake Factory's financial indicators show a revenue growth of 5.89%, a high net margin of 2.16%, and an ROE of 5.54%, but a lower ROA of 0.65% and a high debt-to-equity ratio of 5.79.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:00 pm

CTSH

Cognizant Tech Solns (NASDAQ:CTSH) has received mixed analyst ratings over the past quarter, with 12 analysts offering diverse opinions. The average 12-month price target is $74.83, up from the previous $73.00, with a high estimate of $90.00 and a low of $65.00. Analysts from firms like Barclays, Citigroup, and Jefferies have raised their price targets, while others from BMO Capital, JP Morgan, and Morgan Stanley have lowered theirs. Cognizant's financial performance shows a positive revenue trend, an impressive net margin, and strong ROA, but a below-average ROE and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 3:00 pm

IAG

IAMGOLD Corporation reported its Q4 2023 production results, achieving 465,000 ounces of gold, at the top end of its annual guidance. Essakane and Westwood mines exceeded expectations, with Côté Gold commissioning on track for initial production in March 2024. The company will release full financial results on February 15, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:40 pm

DTSS

Datasea Inc. (NASDAQ:DTSS) pre-announced an estimated revenue of $18.2M for the first half of FY 2024, marking a significant increase of approximately 1,037.5% YoY. This growth is attributed to the success of their 5G messaging and Acoustic Intelligence businesses. However, these figures are preliminary and subject to change upon completion of standard closing procedures. The final financial statement is scheduled for release on February 14, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:36 pm

PFE

The National Institute for Health and Care Excellence (NICE) has recommended the use of talazoparib for treating advanced BRCA1/2-mutant, HER2– breast cancer. This recommendation could potentially increase the usage of talazoparib, which is a positive development for its manufacturer. Pfizer Inc. (PFE), the maker of talazoparib, may experience a positive impact on its stock as this recommendation could lead to increased sales of the drug.

Portfolio Pulse from Benzinga Newsdesk

January 23, 2024 | 2:34 pm

VZ

Verizon Communications Inc (NYSE:VZ) reported Q4 FY23 results with a slight sales decline but beat consensus estimates on both revenue and adjusted EPS. Wireless service revenue grew, driven by TracFone ownership, a premium Unlimited strategy, and pricing actions. The company saw significant postpaid phone and broadband net additions, with the consumer segment showing improved EBITDA margin. Verizon's FY24 outlook projects wireless service revenue growth and an adjusted EPS in line with consensus estimates. VZ shares rose 3.46% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 23, 2024 | 2:26 pm

AAPL

AMD

BAC

BTCUSD

BYDDY

NFLX

TCEHY

TTE

Bitcoin has plummeted below $39K, erasing gains since the US spot ETF launch. Shiba Inu's burn rate spikes, and analysts comment on crypto volatility. US stocks brace for earnings reports, with defensive stocks highlighted. JPMorgan is bearish on the S&P 500. US politics feature Trump's comments and potential UAW Biden endorsement. Russia-West tensions rise, and China's economy stumbles but still attracts investors. Apple faces criticism and rolls out updates, while AMD's future is uncertain. Tencent sees workforce cuts but shares surge. BYD challenges Tesla with new electric vehicles. Netflix's studio head departs, and Bank of America lays off bankers in Asia. TotalEnergies expands in offshore energy.

Portfolio Pulse from Akanksha Bakshi

January 23, 2024 | 2:15 pm